title: Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: M
authors.initials: M
authors.lastname: Pepe
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: C
authors.initials: C
authors.lastname: Anasetti
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: W
authors.initials: W
authors.lastname: Bensinger
authors.forename: C D
authors.initials: CD
authors.lastname: Buckner
authors.forename: R A
authors.initials: RA
authors.lastname: Cliff
authors.forename: K
authors.initials: K
authors.lastname: Doney
authors.forename: J
authors.initials: J
authors.lastname: Hansen
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000601:surgery*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery*; D015470:Leukemia, Myeloid, Acute / Q000601:surgery*; D008727:Methotrexate / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D006680:HLA Antigens; D016572:Cyclosporine; D008727:Methotrexate